Professor Shoji Tsuji and Lecturer Atsushi Iwata of the Department of Neurology, The University of Tokyo Hospital (hereinafter referred to as the University of Tokyo Hospital) have begun clinical research on "Wasure Nabito," a communication tool for patients with dementia.You can view the test results at the University of Tokyo Hospital outside, and you can talk with doctors and pharmacists by message.
According to the University of Tokyo, "Wasure Navito" was developed by the University of Tokyo Hospital under the supervision of Eisai Co., Ltd., a major pharmaceutical company, and Cocokara Fine Inc., a dispensing pharmacy chain, with the cooperation of Internet Initiative Co., Ltd., a major IP communication company.
Lending a tablet terminal to dementia patients and their families who registered to participate in clinical research
■ The results of diagnostic imaging, cognitive function tests, blood tests, etc. conducted at the University of Tokyo Hospital can be viewed outside the hospital and compared with past data.
■ You can send a message to the doctor or pharmacist at the University of Tokyo Hospital and have a dialogue outside the outpatient hours.
■ A pharmacist from the Cocokara Fine Group visits your home and gives guidance on taking medication.
■ You can record your daily life by answering the questionnaire displayed when you start the tablet device.
-Has functions such as.
The research group hopes that by utilizing these functions, medical staff will be able to more accurately grasp the progress and physical condition of dementia and mild cognitive impairment, and will facilitate the solution of treatment and long-term care issues.
According to the summary of the Ministry of Health, Labor and Welfare research group, the number of dementia patients in Japan is estimated to be 462 million.The number of patients is expected to increase 2030 times by 1.5, but treatment for dementia needs to be tailored to each patient, and prompt and accurate understanding of the situation is required.
